Potassium Channel-blockers as Therapeutic Agents to Interfere with Bone Resorption of Periodontal Disease

SAGE Publications - Tập 84 Số 6 - Trang 488-499 - 2005
Paloma Valverde1,2, Toshihisa Kawai1,2, Martin A. Taubman1,2
1Department of Immunology, The Forsyth Institute, Boston, MA, USA
2Tufts University School of Dental Medicine, One Kneeland Street, Boston, MA 02111, USA; and

Tóm tắt

Inflammatory lesions of periodontal disease contain all the cellular components, including abundant activated/memory T- and B-cells, necessary to control immunological interactive networks and to accelerate bone resorption by RANKL-dependent and -independent mechanisms. Blockade of RANKL function has been shown to ameliorate periodontal bone resorption and other osteopenic disorders without affecting inflammation. Development of therapies aimed at decreasing the expression of RANKL and pro-inflammatory cytokines by T-cells constitutes a promising strategy to ameliorate not only bone resorption, but also inflammation. Several reports have demonstrated that the potassium channels Kv1.3 and IKCa1, through the use of selective blockers, play important roles in T-cell-mediated events, including T-cell proliferation and the production of pro-inflammatory cytokines. More recently, a potassium channel-blocker for Kv1.3 has been shown to down-regulate bone resorption by decreasing the ratio of RANKL-to-OPG expression by memory-activated T-cells. In this article, we first summarize the mechanisms by which chronically activated/memory T-cells, in concert with B-cells and macrophages, trigger inflammatory bone resorption. Then, we describe the main structural and functional characteristics of potassium channels Kv1.3 and IKCa1 in some of the cells implicated in periodontal disease progression. Finally, this review elucidates some recent advances in the use of potassium channel-blockers of Kv1.3 and IKCa1 to ameliorate the clinical signs or side-effects of several immunological disorders and to decrease inflammatory bone resorption in periodontal disease. ABBREVIATIONS: AICD, activation-induced cell death; APC, antigen-presenting cells; B(K), large conductance; CRAC, calcium release-activated calcium channels; DC, dendritic cell; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IFN-γ, interferon-γ; IP3, inositol (1,4,5)-triphosphate; (K)ir, inward rectifier; JNK, c-Jun N-terminal kinase; I(K), intermediate conductance; LPS, lipopolysaccharide; L, ligand; MCSF, macrophage colony-stimulating factor; MHC, major histocompatibility complex; NFAT, nuclear factor of activated T-cells; RANK, receptor activator of nuclear factor-κB; TCM, central memory T-cells; TEM, effector memory T-cells; TNF, tumor necrosis factor; TRAIL, TNF-related apoptosis-inducing ligand; OPG, osteoprotegerin; Omp29, 29-kDa outer membrane protein; PKC, protein kinase C; PLC, phospholipase C; RT-PCR, reverse-transcriptase polymerase chain-reaction; S(K), small conductance; TCR, T-cell receptor; and (K)v, voltage-gated.

Từ khóa


Tài liệu tham khảo

10.1006/bbrc.1998.9294

Amigorena S, Choquet D, Teillaud JL, Korn H, Fridman WH -1990- Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K+ channels. J Immunol 144:2038–2045.

10.1113/jphysiol.1992.sp019438

Arkett SA, Dixon J, Yang JN, Sakai DD, Minkin C, Sims SM -1994- Mammalian osteoclasts express a transient potassium channel with properties of Kv1.3. Receptors Channels 2:281–293.

10.1016/S0140-6736(01)05415-0

10.1034/j.1600-065X.2003.00018.x

10.1016/S1286-4579(00)01272-7

10.1034/j.1399-302X.1999.140309.x

10.1128/IAI.67.6.2804-2809.1999

10.1902/jop.1973.44.12.770

10.4049/jimmunol.166.2.936

10.1073/pnas.241497298

Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Leese PT, Dunstan CR -2001- The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 1:348–360.

10.1074/jbc.M308062200

10.1016/S1359-6101(03)00024-8

Boltchi FE, Rees TD, Iacopino AM -1999- Cyclosporine A-induced gingival overgrowth: a comprehensive review. Quintessence Int 30:775–783.

Brent LH, Butler JL, Woods WT, Bubien JK -1990- Transmembrane ion conductance in human B lymphocyte activation. J Immunol 145:2381–2389.

10.1023/A:1010958907271

10.1124/mol.63.2.409

10.1097/00007890-200012270-00011

10.1016/S0041-0101(01)00120-9

10.1016/j.tips.2004.03.010

10.1038/emm.2003.51

10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X

10.1016/S0194-5998(99)70374-8

10.1111/j.1600-0757.1993.tb00221.x

10.1016/S0092-8674(00)80571-1

10.1177/10454411010120030101

10.1111/j.0906-6713.2004.003560.x

10.1097/00002281-200305000-00011

10.1126/science.289.5484.1501

10.1111/j.1600-051X.1985.tb00936.x

10.1111/j.1600-0757.1994.tb00021.x

10.1002/jbmr.5650111202

10.1242/jcs.00062

10.1074/jbc.M011342200

Flanagan AM, Massay HM -2003- Generating human osteoclasts in vitro from bone marrow and peripheral blood. Methods Mol Med 80:113–128.

Fujihashi K, Yamamoto M, Hiroi T, Bamberg TV, McGhee JR, Kiyono H -1996- Selected Th1 and Th2 cytokine mRNA expression by CD4+ T cells isolated from human gingival tissues. Clin Exp Immunol 103:422–428.

10.1111/j.1399-302X.1991.tb00507.x

10.1111/j.1399-302X.1992.tb00514.x

10.1146/annurev.immunol.16.1.111

10.1128/JCM.37.12.4028-4033.1999

Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, et al. -1994- Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol 45:1227–1234.

10.1016/j.sbi.2004.06.008

10.1074/jbc.274.36.25237

10.4049/jimmunol.171.10.5130

10.1146/annurev.micro.57.030502.090908

Hille B -2001- Ionic channels of excitable membranes. 3rd ed. Sunderland, MA: Sinauer Associates.

10.1074/jbc.M213067200

10.1007/s001090100226

10.1006/bbrc.2000.4130

10.1097/01.bor.0000127825.05580.eb

10.1128/IAI.68.10.5645-5651.2000

10.1016/j.bone.2004.02.009

10.1002/glia.1111

10.2174/1389450013348173

10.1038/nature01580

Kajiya H, Okamoto F, Fukushima H, Takada K, Okabe K -2003- Mechanism and role of high-potassium-induced reduction of intracellular Ca2+ concentration in rat osteoclasts. Am J Physiol Cell Physiol 285:C457–C466.

10.4049/jimmunol.164.4.2102

10.4049/jimmunol.171.1.142

Khoori AH, Einollahi B, Ansari G, Moozeh MB -2003- The effect of cyclosporine with or without nifedipine on gingival overgrowth in renal transplant patients. J Can Dent Assoc 69:236–241.

10.1210/endo.142.12.8536

10.1111/j.1600-0765.1989.tb02000.x

10.2174/1381612013397799

10.1074/jbc.M206421200

10.1038/16852

10.1038/46303

Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, et al. -1997- Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol 158:5120–5128.

10.1006/cimm.1999.1569

10.1016/j.smim.2003.09.002

10.1016/j.cytogfr.2003.10.005

10.1016/S0092-8674(00)81569-X

10.1016/S0006-291X(03)00695-8

10.1084/jem.191.7.1167

10.4049/jimmunol.167.5.2625

10.1177/154405910408300216

10.1023/A:1011064007686

10.1615/CritRevImmunol.v23.i12.50

10.1099/00221287-147-9-2461

Page RC, Schroeder HA -1976- Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 34:235–249.

Panayi GS -1995- Treating rheumatoid arthritis with clotrimazole. Nat Med 1:977–978.

Partiseti M, Choquet D, Diu A, Korn H -1992- Differential regulation of voltage- and calcium-activated potassium channels in human B lymphocytes. J Immunol 148:3361–3368.

Partiseti M, Korn H, Choquet D -1993- Pattern of potassium channel expression in proliferating B lymphocytes depends upon the mode of activation. J Immunol 151:2462–2470.

10.1016/j.biolcel.2003.10.008

10.1902/jop.1993.64.8s.819

10.1385/IR:28:3:285

10.1146/annurev.immunol.22.012703.104702

10.1021/bi025722c

10.1002/art.11150

10.1111/j.1600-051X.1991.tb02310.x

10.1111/j.1600-051X.1998.tb02419.x

Socransky SS, Haffajee AD, Ximenez-Fyvie LA, Feres M, Mager D -2000- Ecological considerations in the treatment of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis periodontal infections. Periodontol 2000 20:341–362.

10.1182/blood-2002-05-1433

10.1128/IAI.66.10.5008-5019.1998

10.1186/1479-5876-2-6

Sutro JB, Vayuvegula BS, Gupta S, Cahalan MD -1989- Voltage-sensitive ion channels in human B lymphocytes. Adv Exp Med Biol 254:113–122.

10.1016/S1534-5807(02)00369-6

10.1177/00220345000790080401

10.1016/0003-9969(76)90055-8

10.1177/10454411010120020301

Taubman MA, Ebersole JL, Smith DJ -1982- Association between systemic and local antibody and periodontal diseases. In: Host parasite interactions in periodontal diseases. Genco R, Mergenhagen SE, editors. Washington, DC: ASM Press, pp. 283–298.

Taubman MA, Eastcott JW, Shimauchi H, Takeichi O, Smith DJ -1994- Modulatory role of T lymphocytes in periodontal inflammation. In: Molecular pathogenesis of periodontal disease. Genco R, Hamada S, Lehner T, McGhee JR, Mergenhagen SE, editors. Washington, DC: ASM Press, pp. 147–157.

10.1126/science.289.5484.1504

10.1177/154411130301400402

10.1111/j.1600-0765.1999.tb02222.x

10.1172/JCI10763

10.1146/annurev.immunol.20.100301.064753

10.1073/pnas.0136772100

10.1128/IAI.25.1.427-439.1979

Valverde P, Kawai T, Taubman MA -2004- Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J Bone Miner Res 19:155–164.

10.1124/mol.65.6.1364

10.1074/jbc.M304388200

10.1016/j.febslet.2004.07.030

10.1172/JCI0214114

10.1002/1521-4141(200204)32:4<1090::AID-IMMU1090>3.0.CO;2-P

10.1902/jop.1991.62.3.211

Wilson M -1995- Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis. Sci Pro 78:19–34.

Wittrant Y, Theoleyre S, Chipoy C, Padrines M, Blanchard F, Heymann D, et al. -2004- RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta 1704:49–57.

10.1359/JBMR.041022

10.1073/pnas.97.14.8151

Wulff H, Beeton C, Chandy KG -2003a- Potassium channels as therapeutic targets for autoimmune disorders. Curr Opin Drug Discov Devel 6:640–647.

10.1172/JCI16921

10.4049/jimmunol.173.2.776

10.1111/j.1600-0765.1993.tb01076.x

10.1073/pnas.95.7.3597

Yu FH, Catterall WA -2004- The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis. Sci STKE 253:15–20.

Yun TJ, Chaudhary PM, Shu GL, Frazer JK, Ewings MK, Schwartz SM, et al. -1998- OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol 161:6113–6121.

10.1182/blood-2004-03-1196

Thông tin
Thông tin xuất bản

SAGE Publications

Tập 84 Số 6

488-499

Thông tin tác giả